LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,608,083 | +40.0% | 60,215 | +68.5% | 0.00% | – |
Q2 2023 | $2,576,421 | -27.2% | 35,734 | -25.7% | 0.00% | – |
Q1 2023 | $3,537,000 | +136253.1% | 48,089 | +23.8% | 0.00% | – |
Q4 2022 | $2,594 | -99.9% | 38,833 | -3.2% | 0.00% | – |
Q3 2022 | $3,454,000 | -2.1% | 40,105 | +1.4% | 0.00% | – |
Q2 2022 | $3,528,000 | -24.5% | 39,549 | -4.8% | 0.00% | -100.0% |
Q1 2022 | $4,675,000 | -24.2% | 41,558 | +4.1% | 0.00% | 0.0% |
Q4 2021 | $6,167,000 | +10.5% | 39,923 | -0.4% | 0.00% | 0.0% |
Q3 2021 | $5,582,000 | -25.4% | 40,068 | -29.7% | 0.00% | 0.0% |
Q2 2021 | $7,481,000 | +8.1% | 57,027 | +25.6% | 0.00% | 0.0% |
Q1 2021 | $6,923,000 | +41.1% | 45,413 | -7.9% | 0.00% | 0.0% |
Q4 2020 | $4,906,000 | +12.1% | 49,321 | +8.0% | 0.00% | 0.0% |
Q3 2020 | $4,376,000 | +71.3% | 45,680 | +100.1% | 0.00% | – |
Q2 2020 | $2,554,000 | +41.5% | 22,831 | -8.0% | 0.00% | – |
Q1 2020 | $1,805,000 | -82.3% | 24,825 | -74.5% | 0.00% | -100.0% |
Q4 2019 | $10,170,000 | +10.3% | 97,513 | +5.3% | 0.00% | 0.0% |
Q3 2019 | $9,222,000 | +246.7% | 92,638 | +297.0% | 0.00% | +100.0% |
Q2 2019 | $2,660,000 | -13.0% | 23,333 | -4.0% | 0.00% | 0.0% |
Q1 2019 | $3,057,000 | -67.6% | 24,314 | -65.1% | 0.00% | -50.0% |
Q4 2018 | $9,443,000 | +15.8% | 69,584 | +134.2% | 0.00% | 0.0% |
Q3 2018 | $8,156,000 | +339.0% | 29,707 | +231.2% | 0.00% | – |
Q2 2018 | $1,858,000 | -44.1% | 8,970 | -55.4% | 0.00% | -100.0% |
Q1 2018 | $3,325,000 | -43.7% | 20,132 | -53.3% | 0.00% | 0.0% |
Q4 2017 | $5,907,000 | +179.6% | 43,142 | +175.2% | 0.00% | – |
Q3 2017 | $2,113,000 | +142.6% | 15,676 | +118.5% | 0.00% | – |
Q2 2017 | $871,000 | +38.9% | 7,175 | +21.1% | 0.00% | – |
Q1 2017 | $627,000 | +364.4% | 5,925 | +344.8% | 0.00% | – |
Q4 2016 | $135,000 | +187.2% | 1,332 | +187.7% | 0.00% | – |
Q3 2016 | $47,000 | -89.9% | 463 | -88.1% | 0.00% | – |
Q2 2016 | $465,000 | +511.8% | 3,895 | +449.4% | 0.00% | – |
Q1 2016 | $76,000 | +590.9% | 709 | +609.0% | 0.00% | – |
Q4 2015 | $11,000 | -98.8% | 100 | -99.4% | 0.00% | – |
Q4 2014 | $953,000 | +100.2% | 17,909 | +63.1% | 0.00% | – |
Q3 2013 | $476,000 | -37.5% | 10,981 | -46.0% | 0.00% | – |
Q2 2013 | $761,000 | – | 20,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $8,459 | 3.32% |
VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |